Hodgkinsine B
CAS: 586955-76-2
Ref. 3D-LYA95576
| 5mg | Nachfragen | ||
| 10mg | Nachfragen | ||
| 25mg | Nachfragen | ||
| 50mg | Nachfragen |
Produktinformation
Hodgkinsine B is a potent inhibitor of the kinase activity of nintedanib, a drug used to treat cancer. It was originally isolated from Chinese urine and has shown promising results in inhibiting the growth of cancer cells. Hodgkinsine B has been shown to induce apoptosis, or programmed cell death, in human tumor cells by disrupting the signaling pathways that promote cell survival. This compound also exhibits analogs of glimepiride, which is used to treat diabetes. Additionally, Hodgkinsine B has been found to have potential therapeutic applications as an inhibitor for apomorphine-induced dyskinesia and as an anti-inflammatory agent due to its ability to inhibit vanillin-induced edema. Overall, Hodgkinsine B shows great promise as a potential treatment for cancer and other diseases.
Chemische Eigenschaften
Technische Anfrage zu: 3D-LYA95576 Hodgkinsine B
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
